Institutional investors purchased a net $521.5 thousand shares of NNVC during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 5.29% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 129.7 Thousand shares of NanoViricides Inc
CITADEL ADVISORS LLC Bought 59.8 Thousand shares of NanoViricides Inc
UBS SECURITIES LLC Bought 22.1 Thousand shares of NanoViricides Inc